Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.53 USD | +1.70% | -3.62% | -.--% |
14/05 | Kyverna Therapeutics Q1 Loss Narrows | MT |
14/05 | Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
54Cr | - | - | - | - | - | |
5.46TCr | - | |||||
3.99TCr | ||||||
2.69TCr | ||||||
2.62TCr | ||||||
1.88TCr | - |